C07C 311/64
X and y being nitrogen atoms
Official title: X and Y being nitrogen atoms, e.g. N-sulfonylguanidine
C07C311/64 (X and y being nitrogen atoms) appears on 38 US grants and 21 published applications in this corpus.
Search patents in C07C- Granted patents
- 38
- Published applications
- 21
- Assignees
- 35
- Inventors
- 133
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 5 | 0 |
| 2003 | 1 | 4 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 2 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 3 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections5 May 2026US 12,616,670 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Compounds and compositions for intracellular delivery of therapeutic agents10 Jun 2025US 12,324,859 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents1 Apr 2025US 12,263,248 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents8 Dec 2020US 10,857,105 B2MordernaTX, Inc.
- Reaction products of guanidine compounds or salts thereof, polyepoxides and polyhalogens6 Sep 2016US 9,435,045 B2Rohm and Haas Electronic Materials LLC
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents17 Jul 2025US 2025/0228777 A1ModernaTX, Inc.
- Sulfonamide derivatives and their use as soluble epoxide hydrolase inhibitors13 Feb 2025US 2025/0049736 A1
- N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections11 May 2023US 2023/0146507 A1Helmholtz-Zentrum FüR Infektionsforschung GmbH
- Compounds and compositions for intracellular delivery of therapeutic agents29 Dec 2022US 2022/0409536 A1ModernaTX, Inc.
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- Ubiquitin ligase inhibitors41US 7,915,293 B2Rigel Pharmaceuticals, Inc. · 2011
- Multicatalytic protease inhibitors39US 5,614,649 ACephalon, Inc. · 1997
- Multicatalytic protease inhibitors33US 5,550,262 ACephalon, Inc. · 1996
- Multicatalytic protease inhibitors33US 5,990,083 ACephalon, Inc. · 1999